CA Stock MarketDetailed Quotes

Biosyent Inc (RX)

Watchlist
  • 14.050
  • +0.090+0.64%
15min DelayMarket Closed Jun 1 16:00 ET
160.71MMarket Cap17.92P/E (TTM)

Biosyent Inc (RX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
26.68%13.91M
22.90%43.05M
9.95%9.67M
27.90%12.22M
13.80%10.18M
41.96%10.98M
10.89%35.03M
6.32%8.8M
7.72%9.56M
12.33%8.94M
Operating revenue
26.68%13.91M
22.90%43.05M
9.95%9.67M
27.90%12.22M
13.80%10.18M
41.96%10.98M
10.89%35.03M
6.32%8.8M
7.72%9.56M
12.33%8.94M
Cost of revenue
41.57%3.74M
40.62%10.09M
35.56%2.23M
42.78%2.95M
20.97%2.27M
66.17%2.64M
19.73%7.17M
4.62%1.64M
14.40%2.07M
27.80%1.87M
Gross profit
21.96%10.17M
18.33%32.96M
4.07%7.45M
23.78%9.27M
11.90%7.91M
35.70%8.34M
8.82%27.86M
6.72%7.15M
6.01%7.49M
8.84%7.07M
Operating expense
24.72%6.72M
15.21%21.65M
5.46%5.06M
21.41%5.86M
4.45%5.35M
32.95%5.39M
4.03%18.79M
-7.64%4.8M
12.36%4.83M
9.02%5.12M
Selling and administrative expenses
22.46%6.23M
12.18%19.79M
5.59%4.55M
13.38%5.17M
2.31%5.04M
32.16%5.09M
2.19%17.65M
-12.62%4.31M
9.76%4.56M
9.96%4.92M
-Selling and marketing expense
22.49%2.23M
8.80%7.45M
-23.11%1.43M
20.41%2.13M
-3.76%2.07M
70.19%1.82M
-9.40%6.85M
-28.50%1.86M
7.91%1.77M
17.36%2.15M
-General and administrative expense
22.45%4M
14.32%12.34M
27.32%3.12M
8.93%3.04M
7.03%2.97M
17.50%3.27M
11.22%10.79M
5.05%2.45M
10.97%2.79M
4.83%2.77M
Research and development costs
--0
99.01%341.05K
38.07%76.23K
98.00%127.5K
73.28%47.94K
270.87%89.38K
105.80%171.37K
32.90%55.21K
219.93%64.4K
--27.67K
Depreciation amortization depletion
131.53%488.96K
44.50%852.49K
-4.17%226.46K
73.06%202.21K
74.59%212.64K
83.66%211.18K
29.56%589.95K
94.74%236.32K
4.38%116.84K
9.11%121.8K
-Depreciation and amortization
131.53%488.96K
44.50%852.49K
-4.17%226.46K
73.06%202.21K
74.59%212.64K
83.66%211.18K
29.56%589.95K
94.74%236.32K
4.38%116.84K
9.11%121.8K
Provision for doubtful accounts
--661
-27.68%98.71K
----
----
----
--0
-2.73%136.49K
258.76%136.49K
--0
--0
Other operating expenses
----
126.79%563.97K
85.42%103.56K
329.73%357.33K
6.00%48.3K
-14.54%54.79K
110.87%248.68K
-2.56%55.85K
1,059.88%83.15K
21.92%45.57K
Operating profit
16.93%3.45M
24.81%11.31M
1.25%2.39M
28.09%3.41M
31.45%2.57M
41.03%2.95M
20.31%9.06M
56.03%2.36M
-3.84%2.66M
8.36%1.95M
Net non-operating interest income (expenses)
-18.52%135.18K
-26.20%759.75K
-28.37%176.29K
-9.52%219.25K
-11.38%198.3K
-47.70%165.91K
-3.13%1.03M
-24.46%246.12K
-11.73%242.31K
-17.01%223.78K
Non-operating interest income
-6.83%166.79K
-25.67%809.1K
-27.81%187.77K
-9.93%231.39K
-11.67%210.93K
-46.21%179.01K
-3.76%1.09M
-23.99%260.09K
-11.87%256.89K
-16.79%238.79K
Non-operating interest expense
141.29%31.62K
-16.57%49.35K
-17.84%11.48K
-16.72%12.14K
-15.84%12.63K
-15.97%13.1K
-13.53%59.15K
-14.78%13.97K
-14.06%14.58K
-13.46%15.01K
Other net income (expenses)
-810.65%-297.54K
86.22%-42.89K
75.44%-87.17K
-69.95%21.5K
27.40%-19.09K
2,832.90%41.87K
-393.16%-311.26K
-2,244.11%-354.98K
257.05%71.55K
50.97%-26.29K
Gain on sale of security
-158.53%-24.51K
-136.11%-42.89K
-216.17%-87.17K
-69.95%21.5K
27.40%-19.09K
2,832.90%41.87K
288.17%118.76K
353.23%75.04K
257.05%71.55K
50.97%-26.29K
Special income (charges)
---273.03K
--0
----
----
----
--0
---430.02K
----
----
----
-Less:Restructuring and mergern&acquisition
--273.03K
----
----
----
----
--0
----
----
----
----
-Less:Impairment of capital assets
----
--0
----
----
----
----
--430.02K
----
----
----
Income before tax
4.08%3.29M
22.97%12.03M
10.11%2.48M
22.67%3.65M
27.71%2.75M
31.16%3.16M
14.63%9.78M
21.36%2.25M
-2.84%2.98M
6.55%2.15M
Income tax
12.44%940.48K
20.12%3.02M
-23.70%486.6K
44.95%967.1K
27.71%727.64K
31.16%836.44K
21.15%2.51M
57.87%637.72K
-6.20%667.21K
6.55%569.77K
Earnings from equity interest net of tax
Net income
1.07%2.34M
23.96%9.01M
23.47%1.99M
16.22%2.68M
27.71%2.02M
31.16%2.32M
12.54%7.27M
11.19%1.61M
-1.83%2.31M
6.55%1.58M
Net income continuous operations
1.07%2.34M
23.96%9.01M
23.47%1.99M
16.22%2.68M
27.71%2.02M
31.16%2.32M
12.54%7.27M
11.19%1.61M
-1.83%2.31M
6.55%1.58M
Noncontrolling interests
Net income attributable to the company
1.07%2.34M
23.96%9.01M
23.47%1.99M
16.22%2.68M
27.71%2.02M
31.16%2.32M
12.54%7.27M
11.19%1.61M
-1.83%2.31M
6.55%1.58M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
1.07%2.34M
23.96%9.01M
23.47%1.99M
16.22%2.68M
27.71%2.02M
31.16%2.32M
12.54%7.27M
11.19%1.61M
-1.83%2.31M
6.55%1.58M
Diluted earnings per share
0.49%0.207
27.59%0.8
26.31%0.1768
19.60%0.238
31.62%0.179
35.53%0.206
15.90%0.627
12.90%0.14
0.00%0.199
10.57%0.136
Basic earnings per share
0.50%0.202
27.11%0.783
28.14%0.1768
19.49%0.233
31.34%0.176
34.90%0.201
16.01%0.616
14.05%0.138
0.00%0.195
10.74%0.134
Dividend per share
10.00%0.055
11.11%0.2
11.11%0.05
11.11%0.05
11.11%0.05
11.11%0.05
12.50%0.18
12.50%0.045
12.50%0.045
12.50%0.045
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 26.68%13.91M22.90%43.05M9.95%9.67M27.90%12.22M13.80%10.18M41.96%10.98M10.89%35.03M6.32%8.8M7.72%9.56M12.33%8.94M
Operating revenue 26.68%13.91M22.90%43.05M9.95%9.67M27.90%12.22M13.80%10.18M41.96%10.98M10.89%35.03M6.32%8.8M7.72%9.56M12.33%8.94M
Cost of revenue 41.57%3.74M40.62%10.09M35.56%2.23M42.78%2.95M20.97%2.27M66.17%2.64M19.73%7.17M4.62%1.64M14.40%2.07M27.80%1.87M
Gross profit 21.96%10.17M18.33%32.96M4.07%7.45M23.78%9.27M11.90%7.91M35.70%8.34M8.82%27.86M6.72%7.15M6.01%7.49M8.84%7.07M
Operating expense 24.72%6.72M15.21%21.65M5.46%5.06M21.41%5.86M4.45%5.35M32.95%5.39M4.03%18.79M-7.64%4.8M12.36%4.83M9.02%5.12M
Selling and administrative expenses 22.46%6.23M12.18%19.79M5.59%4.55M13.38%5.17M2.31%5.04M32.16%5.09M2.19%17.65M-12.62%4.31M9.76%4.56M9.96%4.92M
-Selling and marketing expense 22.49%2.23M8.80%7.45M-23.11%1.43M20.41%2.13M-3.76%2.07M70.19%1.82M-9.40%6.85M-28.50%1.86M7.91%1.77M17.36%2.15M
-General and administrative expense 22.45%4M14.32%12.34M27.32%3.12M8.93%3.04M7.03%2.97M17.50%3.27M11.22%10.79M5.05%2.45M10.97%2.79M4.83%2.77M
Research and development costs --099.01%341.05K38.07%76.23K98.00%127.5K73.28%47.94K270.87%89.38K105.80%171.37K32.90%55.21K219.93%64.4K--27.67K
Depreciation amortization depletion 131.53%488.96K44.50%852.49K-4.17%226.46K73.06%202.21K74.59%212.64K83.66%211.18K29.56%589.95K94.74%236.32K4.38%116.84K9.11%121.8K
-Depreciation and amortization 131.53%488.96K44.50%852.49K-4.17%226.46K73.06%202.21K74.59%212.64K83.66%211.18K29.56%589.95K94.74%236.32K4.38%116.84K9.11%121.8K
Provision for doubtful accounts --661-27.68%98.71K--------------0-2.73%136.49K258.76%136.49K--0--0
Other operating expenses ----126.79%563.97K85.42%103.56K329.73%357.33K6.00%48.3K-14.54%54.79K110.87%248.68K-2.56%55.85K1,059.88%83.15K21.92%45.57K
Operating profit 16.93%3.45M24.81%11.31M1.25%2.39M28.09%3.41M31.45%2.57M41.03%2.95M20.31%9.06M56.03%2.36M-3.84%2.66M8.36%1.95M
Net non-operating interest income (expenses) -18.52%135.18K-26.20%759.75K-28.37%176.29K-9.52%219.25K-11.38%198.3K-47.70%165.91K-3.13%1.03M-24.46%246.12K-11.73%242.31K-17.01%223.78K
Non-operating interest income -6.83%166.79K-25.67%809.1K-27.81%187.77K-9.93%231.39K-11.67%210.93K-46.21%179.01K-3.76%1.09M-23.99%260.09K-11.87%256.89K-16.79%238.79K
Non-operating interest expense 141.29%31.62K-16.57%49.35K-17.84%11.48K-16.72%12.14K-15.84%12.63K-15.97%13.1K-13.53%59.15K-14.78%13.97K-14.06%14.58K-13.46%15.01K
Other net income (expenses) -810.65%-297.54K86.22%-42.89K75.44%-87.17K-69.95%21.5K27.40%-19.09K2,832.90%41.87K-393.16%-311.26K-2,244.11%-354.98K257.05%71.55K50.97%-26.29K
Gain on sale of security -158.53%-24.51K-136.11%-42.89K-216.17%-87.17K-69.95%21.5K27.40%-19.09K2,832.90%41.87K288.17%118.76K353.23%75.04K257.05%71.55K50.97%-26.29K
Special income (charges) ---273.03K--0--------------0---430.02K------------
-Less:Restructuring and mergern&acquisition --273.03K------------------0----------------
-Less:Impairment of capital assets ------0------------------430.02K------------
Income before tax 4.08%3.29M22.97%12.03M10.11%2.48M22.67%3.65M27.71%2.75M31.16%3.16M14.63%9.78M21.36%2.25M-2.84%2.98M6.55%2.15M
Income tax 12.44%940.48K20.12%3.02M-23.70%486.6K44.95%967.1K27.71%727.64K31.16%836.44K21.15%2.51M57.87%637.72K-6.20%667.21K6.55%569.77K
Earnings from equity interest net of tax
Net income 1.07%2.34M23.96%9.01M23.47%1.99M16.22%2.68M27.71%2.02M31.16%2.32M12.54%7.27M11.19%1.61M-1.83%2.31M6.55%1.58M
Net income continuous operations 1.07%2.34M23.96%9.01M23.47%1.99M16.22%2.68M27.71%2.02M31.16%2.32M12.54%7.27M11.19%1.61M-1.83%2.31M6.55%1.58M
Noncontrolling interests
Net income attributable to the company 1.07%2.34M23.96%9.01M23.47%1.99M16.22%2.68M27.71%2.02M31.16%2.32M12.54%7.27M11.19%1.61M-1.83%2.31M6.55%1.58M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 1.07%2.34M23.96%9.01M23.47%1.99M16.22%2.68M27.71%2.02M31.16%2.32M12.54%7.27M11.19%1.61M-1.83%2.31M6.55%1.58M
Diluted earnings per share 0.49%0.20727.59%0.826.31%0.176819.60%0.23831.62%0.17935.53%0.20615.90%0.62712.90%0.140.00%0.19910.57%0.136
Basic earnings per share 0.50%0.20227.11%0.78328.14%0.176819.49%0.23331.34%0.17634.90%0.20116.01%0.61614.05%0.1380.00%0.19510.74%0.134
Dividend per share 10.00%0.05511.11%0.211.11%0.0511.11%0.0511.11%0.0511.11%0.0512.50%0.1812.50%0.04512.50%0.04512.50%0.045
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On June 1 Eastern Time, Middle East geopolitics took a dramatic turn. Iran's Tasnim News Agency reported that, in light of Israel’s ongoing Show More